search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
HEALTH CARE


B. FRANK GUPTON CO-FOUNDER, PHLOW CORP.; FOUNDER AND CEO, MEDICINES FOR ALL INSTITUTE, VIRGINIA COMMONWEALTH UNIVERSITY, RICHMOND


Gupton had already retired from a long career in pharmaceuticals when VCU asked him to join its faculty in 2007. He became the Floyd D. Gottwald Professor and chair of the department of chemical and life science engineering at the VCU School of Engineering. He has focused on the high cost of medicines worldwide, starting the Medicines for All Institute, which optimizes active pharmaceutical ingredient production and then shares its findings with global manufacturers. He also co-founded pharmaceutical manufacturer Phlow Corp. with Dr. Eric Edwards.


In partnership with the institute and nonprofit drugmaker Civica Inc., Phlow landed a $354 million contract with the U.S. Biomedical Advanced Research and Development Authority (BARDA) to develop a U.S. supply chain for producing essen- tial medications and pharmaceutical ingredients. In Petersburg, Phlow is developing a pharmaceutical hub expected to generate at least 350 jobs. A graduate of the University of Richmond, Georgia Tech and VCU, Gupton was executive director of chemical process development at Boehringer Ingelheim Pharmaceuticals, where he led the team that developed the antiviral AIDS medication nevirapine. Through Medicines for All, he helped cut the drug’s cost by 15%.


DR. J. STEPHEN JONES PRESIDENT AND CEO, INOVA HEALTH SYSTEM, FALLS CHURCH


One of the nation’s top cancer physicians and urologists, Jones not only pilots Inova, the largest private employer in Northern Virginia, but is also a professor of urology at the University of Virginia. Currently, one of his biggest focuses is Inova’s plan to build a $1 billion hospital campus at the shuttered Landmark Mall in Alexandria.


The new hospital, which is replacing the nearly 60-year-old Inova Alexandria Hospital, will include a Level II Trauma Center, a new cancer center and 230 patient rooms. Developers hope to begin construction by 2023 on the hospi- tal and mixed-use project on the site. Jones teaches urology at the Inova


Fairfax Medical Campus, which partnered with U.Va. to start a northern branch of U.Va.’s medical school. In March, it welcomed the first 36 students to the campus. He previously served as president of


Cleveland Clinic Regional Hospitals and Family Health Centers and as professor of surgery at Cleveland Clinic Lerner College of Medicine at Case Western Reserve University. He earned his medical degree from the University of Arkansas for Medical Sciences.


DR. ARTHUR L.


KELLERMANN CEO, VCU HEALTH SYSTEM, RICHMOND


Taking leadership of the VCU Health System, Kellermann leſt a job he loved, as dean of the renowned F. Edward Hébert School of Medicine at the Uniformed Services University


of the Health Sciences in Maryland. The school provides tuition-free instruction to medical students in exchange for an active-duty military service commitment. In October, Kellermann became VCU Health’s CEO, as well as senior vice president for health sciences. He soon stepped up as an outspoken advocate of public health and common-sense COVID-19 prevention, although VCU Health also encountered a couple of bumpy moments during the early days of vaccinations, first delaying second doses for employees in late January in an effort to distrib- ute more first doses, but then quickly reversing course amid concerns from frontline health workers. At USU, Kellermann expanded its research program,


established a new program in health professions education and hired the school’s first associate dean for diversity and inclusion. Kellermann co-edited a 2017 book about combat casualty care in Iraq and Afghanistan. Earlier in his career, Kellermann taught at Atlanta’s Emory University, where he earned his medical degree, and served as founding director of the Emory Center for Injury Control.


DR. K. CRAIG KENT CEO, UVA HEALTH; EXECUTIVE VICE PRESIDENT FOR HEALTH AFFAIRS, UNIVERSITY OF VIRGINIA, CHARLOTTESVILLE


In February 2020, Kent became the new leader of all UVA Health operations. He arrived at a tumultuous time, as the health system had come under fire (along with VCU Health) for its practice of suing low-income and uninsured patients for unpaid bills. Under Kent, UVA Health stopped the lawsuits and canceled past judgments and liens. Kent has stated that he wants to make care affordable and accessible for those with fewer financial resources. Then came COVID-19. The health system was the center of research for coronavirus treatments, vaccines


102 VIRGINIA 500


and other innovations related to the pandemic. Earlier this year, UVA Health became full owner of Novant Health UVA Health System, a Northern Virginia regional health system that had been a joint initiative with North Carolina-based Novant.


WHAT MAKES ME PASSIONATE ABOUT MY WORK: I truly believe in the mission of an academic health system and the differentiated clinical care we provide for our patients and our community. … I am an equally passionate academic researcher of over 30 years. … I [also] love educating the next generation of health care providers.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196